79.79 -0.32 (-0.40%)

44.97% Fall from 52W High

136.3K NSE+BSE Volume

High volume today

NSE 21 Mar, 2025 3:31 PM (IST)



Board Meetings - Mangalam Drugs and Organics Ltd.

The latest board meeting for Mangalam Drugs and Organics Ltd. took place on 13 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
13 Feb 2025 Quarterly Results -
14 Nov 2024 Quarterly Results -
13 Aug 2024 Quarterly Results -
21 May 2024 Audited Results -
15 Mar 2024 Others Inter alia to consider and approve: The proposal of Scheme of Merger.
13 Feb 2024 Quarterly Results -
08 Nov 2023 Quarterly Results -
10 Aug 2023 Quarterly Results -
30 May 2023 Audited Results -
13 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
05 Aug 2022 Quarterly Results -
26 May 2022 Audited & Quarterly Results -
04 Feb 2022 Quarterly Results -
12 Nov 2021 Quarterly Results -
12 Aug 2021 Quarterly Results -
20 May 2021 Audited Results -
11 Feb 2021 Quarterly Results -
12 Nov 2020 Quarterly Results -
10 Aug 2020 Quarterly Results -
29 Jun 2020 Audited Results -
24 Jan 2020 Quarterly Results -
02 Nov 2019 Quarterly Results -
26 Jul 2019 Quarterly Results -
09 May 2019 Audited Results -
11 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Quarterly Results -
28 May 2018 Audited Results -
12 Feb 2018 Quarterly Results -
12 Dec 2017 Interim Dividend -
20 Nov 2017 Quarterly Results -
11 Aug 2017 Quarterly Results -
08 May 2017 Audited Results -
06 Feb 2017 Quarterly Results -
10 Nov 2016 Quarterly Results -
01 Aug 2016 Quarterly Results -
10 Jun 2016 Allotment of Equity Shares (Revised from 06/06/2016)
16 May 2016 Audited Results -
30 Mar 2016 Independent Director Meeting -
14 Jan 2016 Quarterly Results & Others 1. To appoint the Internal Auditor of the Company for the financial year 2015-2016; 2. To appoint the Secretarial Auditor of the Company for the financial year 2015-16.
16 Nov 2015 Allotment of Equity Shares To consider & approve the allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share Warrants which were allotted on preferential basis to Shri.JB Pharma LLP.
21 Oct 2015 Others The Board of Directors have designated Mr. Brijmohan M Dhoot an existing Executive Director of the Company as the Non-Executive Director of the Company with immediate effect.
28 Sep 2015 Others Allotted 26,50,000 convertible share warrants at Rs. 65/- (including premium of Rs. 55/-) to Shri JB Pharma LLP, Promoter group on preferential basis in accordance with the Chapter VII of SEBI.
04 Sep 2015 Others 1. Board of Directors have appointed Mr. Brijmohan M Dhoot who is an existing non Executive Director. 2. Appointed Ms. Nikita Bavishi, as the whole time Company Secretary of the Company Secretary.
06 Aug 2015 Others To consider and approve the issue of such number of Warrants or other securities convertible into equity shares or other securities convertible into equity shares on preferential basis.
04 Aug 2015 Quarterly Results -
15 May 2015 Audited Results -
23 Jan 2015 Quarterly Results -
14 Nov 2014 Quarterly Results -
12 Aug 2014 Quarterly Results -
29 May 2014 Audited Results -
13 Feb 2014 Quarterly Results -
14 Nov 2013 Quarterly Results -
13 Aug 2013 Quarterly Results -
23 May 2013 Audited Results -
12 Feb 2013 Quarterly Results -
08 Nov 2012 Quarterly Results -
13 Aug 2012 Quarterly Results -
23 Jul 2012 Audited Results & Dividend -
19 May 2012 Quarterly Results -
13 Feb 2012 Quarterly Results -
10 Nov 2011 Quarterly Results -
12 Aug 2011 Quarterly Results -
30 May 2011 Audited Results & Dividend -
10 Feb 2011 Quarterly Results -
12 Nov 2010 Quarterly Results (Revised)
29 Jul 2010 Quarterly Results -
29 May 2010 Audited Results -
28 Jan 2010 Quarterly Results -
28 Oct 2009 Quarterly Results -
29 Jul 2009 Quarterly Results -
18 Jun 2009 Audited Results -
29 Jan 2009 Quarterly Results -
24 Oct 2008 Quarterly Results -
31 Jul 2008 Quarterly Results -
20 Jun 2008 Audited Results -
31 Jan 2008 Quarterly Results -
29 Oct 2007 Quarterly Results -
30 Jul 2007 Quarterly Results -
29 Jun 2007 Audited Results & Dividend -
30 Jan 2007 Quarterly Results -
18 Dec 2006 Increase in Authorised Capital -
30 Oct 2006 Quarterly Results Proposal for raising of additional funds
31 Jul 2006 Quarterly Results -
30 Jun 2006 Accounts & Final Dividend -
16 Feb 2006 Resignation of Directors -
27 Jan 2006 Quarterly Results -
28 Oct 2005 Quarterly Results -
27 Jul 2005 Quarterly Results -
10 Jun 2005 Dividend & Accounts -